Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension.
The mechanism of the acute fall of BP following percutaneous transluminal renal angioplasty (PTRA) was studied in four patients with renovascular hypertension caused by fibromuscular dysplasia. One hour after PTRA, systemic blood pressure and plasma renin activity in the ipsilateral renal venous blood decreased significantly (P less than 0.05), but the plasma noradrenaline level in ipsilateral renal venous blood increased significantly (P less than 0.05). At the same time, a platelet-activating factor (PAF) and an unidentified factor that inhibited the aggregation of rabbit platelets induced by PAF, arachidonic acid or ADP were detected in the ipsilateral renal venous blood, but were not found in the contralateral renal venous blood. Plasma noradrenaline level in cubital venous blood decreased significantly (P less than 0.05) after 24 hours as compared with that before PTRA and BP also maintained the normal level. These results suggest that the reduction in plasma renin activity is associated with the acute reduction in BP following PTRA. PAF and an unidentified factor blocking the aggregation of platelets may be involved in ipsilateral renal venous blood following PTRA in patients with renovascular hypertension. The reduction in plasma noradrenaline level is an additional mechanism involved in maintaining normal BP following PTRA in the late stage.
Masugi
F
F
Department of Medicine and Geriatrics, Osaka University Medical School, Japan.
Ogihara
T
T
Saeki
S
S
Sakaguchi
K
K
Kumahara
Y
Y
D000328:Adult; D000800:Angioplasty, Balloon; D001794:Blood Pressure; D005260:Female; D006339:Heart Rate; D006801:Humans; D006978:Hypertension, Renovascular / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D009638:Norepinephrine / Q000097:blood; D010972:Platelet Activating Factor / Q000032:analysis* / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000032:analysis*; D012083:Renin / Q000097:blood; D014556:Urine / Q000032:analysis
D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D012083:Renin; D009638:Norepinephrine